Publications by authors named "A F Alsohaim"

Background Papillary thyroid cancer (PTC), a well-differentiated form of cancer, accounts for the majority of thyroid malignancies, and the incidence of PTC is on the rise. While the rate of PTC recurrence is considered to be low, there are broad spectrums of clinical and biological behavior that can lead to disease recurrence. The American Thyroid Association (ATA) risk stratification system for differentiated thyroid cancer is used as a prognostic tool to guide decision-making and management strategies most likely to achieve a favorable outcome.

View Article and Find Full Text PDF

Occupational radiation exposure can occur due to various human activities, including the use of radiation in medicine. Occupationally exposed personnel surpassing 7.4 millions, and respresent the biggest single group of employees who are exposed to artificial radiation sources at work.

View Article and Find Full Text PDF

Adrenal insufficiency (AI) is a relatively rare disease. While the adrenocorticotropic hormone (ACTH) stimulation test remains as one of the commonly used diagnostic test for AI, to date there is no consensus on the cortisol cutoff value post-ACTH stimulation test. This study aimed to investigate and characterize the cortisol response after the standard ACTH stimulation test in a group of Saudi Arabian patients.

View Article and Find Full Text PDF

Purpose: Primary hyperparathyroidism (PHPT) is a common cause of hypercalcemia and remains understudied within the Arabian population. The present study, the largest of its kind within the Gulf Cooperation Council (GCC) countries, aims to determine the demographics and clinical presentation of PHPT in Saudi Arabia.

Methods: In this multi-center retrospective study involving three tertiary hospitals in different geographic locations of Saudi Arabia namely, Riyadh, Al Ahsa and Jeddah, a total of 205 out of 243 confirmed PHPT cases aged 16 to 93 years old were included (N = 96 from Riyadh; N = 59 from Al Ahsa and N = 50 from Jeddah).

View Article and Find Full Text PDF
Article Synopsis
  • Adalimumab, a monoclonal antibody for autoimmune disorders, can increase the risk of tuberculosis (TB) infection, particularly in TB-endemic regions like Saudi Arabia.
  • A study in Riyadh reviewed medical records of 410 patients treated with adalimumab from 2015 to 2019, focusing on the occurrence of TB infections after therapy.
  • No cases of TB infection or reactivation were found during the follow-up period, and a low percentage (6.6%) tested positive for TB before treatment, with no significant complications attributed to adalimumab.
View Article and Find Full Text PDF